Abstract
Electrospun nanofibers mimic the bone’s extra-cellular matrix and represent an alternative implant coating to enhance implant osseointegration. Approximately 99% of the strontium (Sr2+) in our body deposits in the bone and serves as a stimulator of bone formation. The purpose of this study was to develop an Sr2+-doped coaxial polycaprolactone (PCL)/poly(D,L-lactide-co-glycolide) (PLGA)-polyvinyl alcohol (PVA) nanofiber coating to enhance the osseointegration. An optimized PCL/PLGA (1:1 v/v) sheath fiber formula was identified to match the nanofibers degradation to the implant osseointegration physiology. Scanning electron microscopy images showed that the Sr2+-doped nanofibers had a less dense structure and larger porosity than the nanofibers without Sr2+ doping. A sustained Sr2+ release from the PCL/PLGA-PVA coaxial nanofibers was observed for over two months. The indirect and direct cellular contact studies confirmed the biocompatibility of the Sr2+-doped PCL/PLGA-PVA coaxial nanofibers. The Sr2+-doped nanofibers provided further and significant enhancement of the differentiation of murine pre-osteoblast MC3T3-E1 cells. These findings indicate that Sr2+-doped PCL/PLGA-PVA coaxial nanofibers have a great potential to be applied as a new implant coating matrices.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
